1. Home
  2. ALT vs CHPT Comparison

ALT vs CHPT Comparison

Compare ALT & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • CHPT
  • Stock Information
  • Founded
  • ALT 1997
  • CHPT 2007
  • Country
  • ALT United States
  • CHPT United States
  • Employees
  • ALT N/A
  • CHPT N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • CHPT Industrial Specialties
  • Sector
  • ALT Health Care
  • CHPT Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • CHPT Nasdaq
  • Market Cap
  • ALT 472.3M
  • CHPT 468.9M
  • IPO Year
  • ALT N/A
  • CHPT N/A
  • Fundamental
  • Price
  • ALT $4.55
  • CHPT $0.56
  • Analyst Decision
  • ALT Strong Buy
  • CHPT Hold
  • Analyst Count
  • ALT 8
  • CHPT 10
  • Target Price
  • ALT $21.00
  • CHPT $1.58
  • AVG Volume (30 Days)
  • ALT 2.2M
  • CHPT 19.9M
  • Earning Date
  • ALT 05-08-2025
  • CHPT 06-04-2025
  • Dividend Yield
  • ALT N/A
  • CHPT N/A
  • EPS Growth
  • ALT N/A
  • CHPT N/A
  • EPS
  • ALT N/A
  • CHPT N/A
  • Revenue
  • ALT $20,000.00
  • CHPT $417,083,000.00
  • Revenue This Year
  • ALT N/A
  • CHPT $12.71
  • Revenue Next Year
  • ALT N/A
  • CHPT $27.42
  • P/E Ratio
  • ALT N/A
  • CHPT N/A
  • Revenue Growth
  • ALT N/A
  • CHPT N/A
  • 52 Week Low
  • ALT $3.55
  • CHPT $0.51
  • 52 Week High
  • ALT $11.16
  • CHPT $2.44
  • Technical
  • Relative Strength Index (RSI)
  • ALT 43.21
  • CHPT 38.96
  • Support Level
  • ALT $4.32
  • CHPT $0.56
  • Resistance Level
  • ALT $4.75
  • CHPT $0.64
  • Average True Range (ATR)
  • ALT 0.38
  • CHPT 0.05
  • MACD
  • ALT 0.05
  • CHPT 0.00
  • Stochastic Oscillator
  • ALT 63.22
  • CHPT 34.18

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About CHPT ChargePoint Holdings Inc.

ChargePoint designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.

Share on Social Networks: